Samson Lalhmangaihzuala, Khiangte Vanlaldinpuia, Vanlalngaihawma Khiangte, Zathang Laldinpuii, Thanhming Liana, Chhakchhuak Lalhriatpuia, Zodinpuia Pachuau
Carbohydrates, one of the most abundant biomolecules found in nature, have been seen traditionally as a dietary component of foods. Recent findings, however, have unveiled their medicinal potential in the form of carbohydrates-derived drugs. Their remarkable structural diversity, high optical purity, bioavailability, low toxicity and the presence of multiple functional groups have positioned them as a valuable scaffold and an exciting frontier in contemporary therapeutics. At present, more than 170 carbohydrates-based therapeutics have been granted approval by varying regulatory agencies such as United States Food and Drug Administration (FDA), Japan Pharmaceuticals and Medical Devices Agency (PMDA), Chinese National Medical Products Administration (NMPA), and the European Medicines Agency (EMA)...
March 30, 2024: Molecular Diversity